Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v4-FR
Language French French
Date Updated 2022-06-23 2022-03-02
Drug Identification Number 02215756 02215756
Brand name CAVERJECT STERILE POWDER CAVERJECT STERILE POWDER
Common or Proper name CAVERJECT CAVERJECT
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ALPROSTADIL ALPROSTADIL
Strength(s) 20MCG 20MCG
Dosage form(s) POWDER FOR SOLUTION LIQUID KIT POWDER FOR SOLUTION LIQUID KIT
Route of administration INTRACAVERNOSAL INTRACAVERNOSAL INTRACAVERNOSAL INTRACAVERNOSAL
Packaging size 5 X 20MCG 5 X 20MCG
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-03-25 2022-03-25
Actual start date 2022-03-02 2022-03-02
Estimated end date 2022-10-31 2022-05-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Currently under preventive allocation
Health Canada comments